- Atreca Inc Annual Shareholders Meeting TranscriptJun 13, 2023
- Q4 2022 Atreca Inc Earnings Call TranscriptMar 29, 2023€1.18 (+9.26%)Earnings
- Atreca Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- Atreca Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Atreca Inc at Stifel Healthcare Conference TranscriptNov 15, 2022
- Atreca Inc at Cowen IO Next Summit (Virtual) TranscriptNov 11, 2022
- Atreca Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 13, 2022
- Atreca Inc at Canaccord Genuity Growth Conference TranscriptAug 10, 2022
- Atreca Inc Annual Shareholders Meeting TranscriptJun 08, 2022
- Atreca Inc at Cowen Oncology Innovation Summit: Insights for ASCO & EHA (Virtual) TranscriptJun 02, 2022
- Atreca Inc Phase 1b ATRC-101 Clinical Data Update Call TranscriptJul 29, 2021
- Atreca Inc Turning the Current Cancer Therapeutic Discovery Paradigm on its Head TranscriptFeb 21, 2021
Atreca Inc at Cowen Oncology Innovation Summit: Insights for ASCO & EHA (Virtual) Transcript
Good afternoon, and welcome once again to Cowen & Company's Third Annual Oncology Innovation Summit. I'm Phil Nadeau, one of the biotech analysts here at Cowen. It's my pleasure to moderate our fireside chat with Atreca. We have with us this afternoon, John Orwin, the Chief Executive Officer; Herb Cross, Chief Financial Officer; Tito Serafini, Chief Strategy Officer; Jonathan Benjamin, the SVP of Clinical Research. I believe Alex Gray from Investor Relations is also in the room.
Questions & Answers
John, maybe we'll start with you. Last time, you announced a corporate restructuring to extend your cash runway. Could you discuss how you have prioritized your spend and the impact that's going to have on your operational runway?
Yeah, thanks for the question, Phil. I think we found ourselves in a position where we have seen responses for ATRC-101, our clinical-stage
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)